Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01365728 · ClinicalTrials.gov registry record

An Outcomes Study Comparing the Intralase FS 60 to the Intralase iFS When Performing LASIK Surgery for Nearsightedness

A clinical trial of Myopia and Astigmatism, sponsored by Stanford University.

Completed
Registry status
61
Enrollment target
1
Study location

NCT01365728: Completed study of Myopia and Astigmatism, sponsored by Stanford University.

NCT01365728 is a study of Myopia and Astigmatism that has completed, run by Stanford University. The registered enrollment target is 61 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01365728, a study of Myopia and Astigmatism, has completed, sponsored by Stanford University.

COMPLETED
Registry status
61 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to compare the results of LASIK surgery when using two versions of a femtosecond laser in patients with nearsightedness with and without astigmatism.

Conditions Studied

Interventions

  • PROCEDURE LASIK with the iFS femtosecond laser

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2011-04
Est. Completion 2018-12
Stanford University

1,744 total trials

What the finished NCT01365728 record still lists

NCT01365728 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (77% lower).

The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which LASIK with the iFS femtosecond laser is the first listed.

NCT01365728 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01365728 about?

NCT01365728 is a clinical study titled "An Outcomes Study Comparing the Intralase FS 60 to the Intralase iFS When Performing LASIK Surgery for Nearsightedness". The purpose of the study is to compare the results of LASIK surgery when using two versions of a femtosecond laser in patients with nearsightedness with and without astigmatism.

What is the current status of trial NCT01365728?

This trial is currently completed. The enrollment target is 61 participants. The study started on 2011-04. Estimated completion is 2018-12.

What conditions does trial NCT01365728 study?

This clinical trial studies the following conditions: Myopia, Astigmatism.

What interventions are being tested in trial NCT01365728?

The interventions under investigation include: LASIK with the iFS femtosecond laser (PROCEDURE).

Who is sponsoring clinical trial NCT01365728?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01365728 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01365728's enrollment target sits among peer trials

61 60th of 90 higher than 31 of 90 other Myopia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01365728, the US trial registry maintained by the National Library of Medicine. NCT01365728 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.